These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25591645)

  • 1. [Cerebrolysin in the treatment of brain injuries of moderate severity].
    Talypov AE; Myachin MY; Kuksova NS; Kordonsky AY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):98-106. PubMed ID: 25591645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study.
    Wong GK; Zhu XL; Poon WS
    Acta Neurochir Suppl; 2005; 95():59-60. PubMed ID: 16463821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of neurotrophic treatment on the activation of reparative processes in patients with acute traumatic brain injury].
    Selianina NV; Karakulova IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):46-9. PubMed ID: 22951781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injury.
    Muresanu DF; Ciurea AV; Gorgan RM; Gheorghita E; Florian SI; Stan H; Blaga A; Ianovici N; Iencean SM; Turliuc D; Davidescu HB; Mihalache C; Brehar FM; Mihaescu AS; Mardare DC; Anghelescu A; Chiparus C; Lapadat M; Pruna V; Mohan D; Costea C; Costea D; Palade C; Bucur N; Figueroa J; Alvarez A
    CNS Neurol Disord Drug Targets; 2015; 14(5):587-99. PubMed ID: 25924999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated recovery from acute brain injuries: clinical efficacy of neurotrophic treatment in stroke and traumatic brain injuries.
    Bornstein N; Poon WS
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():43-61. PubMed ID: 22514794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotective treatment of chronic cerebrovascular insufficiency].
    Anisimova AV; Kolesnikova TI; Iutskova EV; Galkin SS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):30-2. PubMed ID: 25176263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study.
    Alvarez XA; Sampedro C; Pérez P; Laredo M; Couceiro V; Hernández A; Figueroa J; Varela M; Arias D; Corzo L; Zas R; Lombardi V; Fernández-Novoa L; Pichel V; Cacabelos R; Windisch M; Aleixandre M; Moessler H
    Int Clin Psychopharmacol; 2003 Sep; 18(5):271-8. PubMed ID: 12920387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular insufficiency (a clinical and electrophysiological study)].
    Damulin IV; Koberskaia NN; Mkhitarian EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(5):32-8. PubMed ID: 18379494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of neurotrophic factors and cognitive function in patients with traumatic brain injury].
    Karakulova YV; Selyanina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):34-37. PubMed ID: 29171486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury.
    Alvarez XA; Sampedro C; Figueroa J; Tellado I; González A; García-Fantini M; Cacabelos R; Muresanu D; Moessler H
    J Neural Transm (Vienna); 2008 May; 115(5):683-92. PubMed ID: 18273537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
    Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury.
    El Sayed I; Zaki A; Fayed AM; Shehata GM; Abdelmonem S
    Neurosurg Rev; 2018 Apr; 41(2):427-438. PubMed ID: 27539610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrolysin: a multi-target drug for recovery after stroke.
    Brainin M
    Expert Rev Neurother; 2018 Aug; 18(8):681-687. PubMed ID: 30004268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials.
    Thome J; Doppler E
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():63-9. PubMed ID: 22514795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asthenic disorders and cognitive dysfunction in patients with tension headache].
    Chutko LS; Surushkina SIu; Rozhkova AV; Iakovenko EA; Bykova IuL; Nikishina IS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):31-5. PubMed ID: 23739500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat.
    Sharma HS; Muresanu DF; Patnaik R; Stan AD; Vacaras V; Perju-Dumbrav L; Alexandru B; Buzoianu A; Opincariu I; Menon PK; Sharma A
    J Nanosci Nanotechnol; 2011 Sep; 11(9):7549-69. PubMed ID: 22097459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
    Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
    Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.